Instrument Inactif

Autres langues ProText Mobility Inc OTC Bulletin Board

Actions

US74371E1055

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

2022

Protext Mobility, Inc et RSAMMDA LLC fournissent la mise à jour des actionnaires

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION	14/11/22
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	01/11/22
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	01/11/22
Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	01/11/22
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP	01/08/22
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended	03/12/21
ProText Mobility : Quarterly Report	21/11/21
ProText Mobility : Notification of Late Filing	16/11/21
PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND	29/10/21
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	29/10/21
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)	07/05/20
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology	30/04/20
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.	19/01/19
Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.	19/01/18
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.	19/01/18
Protext Pharma : Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance	20/09/17
Protext Pharma : to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes	13/09/17
Protext Mobility : Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License	23/05/17
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc	23/05/17
Protext Mobility : Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial	04/05/17

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ProText Mobility Inc OTC Bulletin Board

Actions

US74371E1055

Autres langues

Filtres